HDAC2, a histone deacetylase, reportedly promoted cell cycle progression of breast cancer cell lines, since CRISPR/Cas9‐mediated knockout induced reduction of the cells in S and G2/M phases [17]. The gene discussed is HDAC2; the disease is breast carcinoma.